---
title: "Alexithymia Modulates How Self-Reported Physiological Hyperarousal Affects Risky Choice"
id: "medrxiv-3-feeling-too-much-or-too-little-alexithymia-moderates-how-self-reported"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-3-feeling-too-much-or-too-little-alexithymia-moderates-how-self-reported"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1?rss=1"
published_at: "2026-11-05T09:31:11.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Alexithymia Modulates How Self-Reported Physiological Hyperarousal Affects Risky Choice
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-3-feeling-too-much-or-too-little-alexithymia-moderates-how-self-reported
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1?rss=1)
- **Published At:** 2026-11-05T09:31:11.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The authors tested whether self-reported physiological **hyperarousal** predicts Prospect Theory choice parameters and whether **alexithymia** moderates those associations. The study used self-report scales and a behavioral gambling task. - Sample comprised 68 healthy young adults (mean age 18.94 years, SD = 1.46; 85% women). The DASS-21 anxiety subscale indexed hyperarousal; the TAS-20 measured alexithymia. - Decision behavior came from a 64-trial Mixed Gambles Task. Individual Prospect Theory parameters—loss aversion, value sensitivity, and choice consistency—were estimated via hierarchical Bayesian analysis. - Moderation analyses used Hayes' PROCESS macro with Johnson–Neyman probing to locate conditional effects of TAS-20 on hyperarousal–decision associations. - Results: higher self-reported hyperarousal predicted lower **choice consistency** and lower **value sensitivity**; there was no effect on **loss aversion**. - Alexithymia moderated both observed associations but in distinct ways: the hyperarousal–choice consistency link was significant only below a TAS-20 threshold (51.05), reflecting a monotonic buffering pattern across most participants. - The hyperarousal–value sensitivity association was significant only within a bounded TAS-20 range (45.31–66.08), suggesting intermediate alexithymia may confer maximal vulnerability; this model reached only trend significance and authors treat it as exploratory. - The preprint notes ethical approval by the Universitat de Valencia ethics committee and that all data are available on reasonable request. The report is a preprint and not peer-reviewed.
## Clinical Analysis & Structured Key Points
[](https://www.medrxiv.org/cdn-cgi/content?id=6AtazI94US7Sw1QjgQLrTuztbxH2AQYPBjEc6JVuzH8-1793871104.0950575-1.2.1.1-CcaB3bnr6BD_LBrt7EP_B7ib.ses1GOAjlbUfHgn.niXJXsKtn6OaC_F59WeFdLz) [Skip to main content](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1?rss=1#main-content) [![medRxiv](https://www.medrxiv.org/sites/default/files/medrxiv_inner_logo.png)](https://www.medrxiv.org/) * [Home](https://www.medrxiv.org/) * [Submit](https://www.medrxiv.org/submit-a-manuscript) * [FAQ](https://www.medrxiv.org/about/FAQ) * [Blog](https://connect.medrxiv.org/news/) * [ALERTS / RSS](https://www.medrxiv.org/content/alertsrss) * [Resources](https://connect.medrxiv.org/resources/) * [About](https://www.medrxiv.org/content/about-medrxiv) Search for this keyword [Advanced Search](https://www.medrxiv.org/search) Follow this preprint # Feeling Too Much or Too Little: Alexithymia Moderates How Self-Reported Physiological Hyperarousal Shapes Risky Decisions [ View ORCID Profile](http://orcid.org/0000-0002-0211-9182)Francisco Molins Sr., Blanca Medina-Gascon, [ View ORCID Profile](http://orcid.org/0000-0002-1707-1812)Patricia Mesa-Gresa doi: https://doi.org/10.64898/2026.11.02.26367105 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Francisco Molins Sr. 1 Department of Health Pyschology, Faculty of Health Sciences, Universidad de Alicante, Alicante, Spain; * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Francisco%2BMolins%2B%3Cspan%2Bclass%3D%22nlm-suffix%22%3ESr.%3C/span%3E "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Molins%20F&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3AFrancisco%2BMolins%2BSr.) * [ORCID record for Francisco Molins Sr.](http://orcid.org/0000-0002-0211-9182 "Open in new tab") Blanca Medina-Gascon 2 Department of Psychobiology, Faculty of Psychology and Speech Therapy, Universitat de Valencia, Valencia, Spain * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Blanca%2BMedina-Gascon%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Medina-Gascon%20B&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3ABlanca%2BMedina-Gascon%2B) Patricia Mesa-Gresa 2 Department of Psychobiology, Faculty of Psychology and Speech Therapy, Universitat de Valencia, Valencia, Spain * [Find this author on Google Scholar](https://www.medrxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Patricia%2BMesa-Gresa%2B "Open in new tab") * [Find this author on PubMed](https://www.medrxiv.org/lookup/external-ref?access_num=Mesa-Gresa%20P&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.medrxiv.org/search/author1%3APatricia%2BMesa-Gresa%2B) * [ORCID record for Patricia Mesa-Gresa](http://orcid.org/0000-0002-1707-1812 "Open in new tab") * For correspondence: patricia.mesa@uv.es * [Abstract](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_art/node:1338541/1) * [Info/History](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1.article-info)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_info/node:1338541/1) * [Metrics](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1.article-metrics)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_metrics/node:1338541/1) * [Data/Code](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1.external-links)[](https://www.medrxiv.org/panels_ajax_tab/article_tab_data_code/node:1338541/1) * [ Preview PDF](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1.full.pdf+html)[](https://www.medrxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:1338541/1) ![Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Background: Embodied cognition frameworks propose that physiological states shape decision-making, yet the contribution of sustained threat-related hyperarousal and individual differences in interoceptive integration remains poorly understood. This study examined whether self-reported physiological hyperarousal predicted Prospect Theory decision parameters: loss aversion, value sensitivity, and choice consistency; and whether alexithymia moderated these associations. Methods: Sixty-eight healthy young adults (M age = 18.94, SD = 1.46; 85% women) completed the DASS-21 anxiety subscale as a measure of hyperarousal, the TAS-20 as a measure of alexithymia, and a 64-trial Mixed Gambles Task; individual Prospect Theory parameters were estimated via hierarchical Bayesian analysis. Moderation analyses were conducted using Hayes' PROCESS macro with Johnson-Neyman probing. Results: Self-reported hyperarousal negatively predicted choice consistency and value sensitivity, but not loss aversion. Alexithymia moderated both effects through distinct conditional patterns: the self-reported hyperarousal-choice consistency association was significant only below a TAS-20 threshold of 51.05 (67.65% of the sample), reflecting monotonic buffering; the self-reported hyperarousal value sensitivity association was significant within a bounded TAS-20 range (45.31-66.08), suggesting that intermediate alexithymia constitutes a zone of maximal vulnerability, though this model only reached trend significance and should be treated as exploratory. No effects emerged for loss aversion. Conclusion: These findings indicate that sustained hyperarousal could selectively degrade evaluative precision and decision consistency, while leaving loss aversion intact. Alexithymia may operate as a stage-specific, conditional moderator of the body-decision relationship. ### Competing Interest Statement The authors have declared no competing interest. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethics committee of the Universitat de Valencia gave ethical approval for this work (Reference: 2023-PSILOG-2558999), in accordance with the Declaration of Helsinki I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes ## Data Availability All data produced in the present study are available upon reasonable request to the authors ## Funder Information Declared Ministerio de Ciencia, Innovación y Universidades, https://ror.org/05r0vyz12, PID2022-138021OA-I00 Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University of Washington, and Vrije Universiteit Amsterdam. [Donate to openRxiv ](https://www.zeffy.com/en-US/donation-form/donate-to-make-a-difference-10981) [ Back to top](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1?rss=1#page) [ Previous](https://www.medrxiv.org/content/10.64898/2026.11.02.26367117v1 "First-trimester nocturnal cardiorespiratory coupling during home sleep testing and later pregnancy complications: a secondary analysis of the nuMoM2b cohort")[Next ](https://www.medrxiv.org/content/10.64898/2026.11.03.26367107v1 "Smaller Cortical Responses to Balance Perturbations in Parkinson's Disease with Freezing of Gait") Posted November 05, 2026. [ Download PDF](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1.full.pdf) Print/Save Options [Download PDF](https://www.medrxiv.org/content/medrxiv/early/2026/11/03/2026.11.02.26367105.full.pdf)Full Text & In-line FiguresXML [More Info](https://www.medrxiv.org/about/FAQ#PrintOptions "More Information on Print/Save Options") [ Author Declarations](https://www.medrxiv.org/content/10.64898/2026.11.02.26367105v1#p-5) [ Data/Code](https://www.medrxiv.org/content/early/2026/11/03/2026.11.02.26367105.external-links) [ Email](https://www.medrxiv.org/ "Email this Article") [ Share](https://www.medrxiv.org/) Feeling Too Much or Too Little: Alexithymia Moderates How Self-Reported Physiological Hyperarousal Shapes Risky Decisions Francisco Molins Sr., Blanca Medina-Gascon, Patricia Mesa-Gresa medRxiv 2026.11.02.26367105; doi: https://doi.org/10.64898/2026.11.02.26367105 [This article is a preprint and has not been certified by peer review [](https://www.medrxiv.org/about/FAQ#unrefereed)[what does this mean?](https://www.medrxiv.org/about/FAQ#unrefereed)]. It reports new medical research that has yet to be evaluated and so should _not_ be used to guide clinical practice. Share This Article: Copy [![Twitter logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/twitter.png)](https://www.medrxiv.org/highwire_log/share/twitter?link=http%3A%2F%2Ftwitter.com%2Fshare%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.02.26367105v1%26text%3DFeeling%2520Too%2520Much%2520or%2520Too%2520Little%253A%2520Alexithymia%2520Moderates%2520How%2520Self-Reported%2520Physiological%2520Hyperarousal%2520Shapes%2520Risky%2520Decisions "Share this on Twitter") [![Facebook logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/fb-blue.png)](https://www.medrxiv.org/highwire_log/share/facebook?link=http%3A%2F%2Fwww.facebook.com%2Fsharer.php%3Fu%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.02.26367105v1%26t%3DFeeling%2520Too%2520Much%2520or%2520Too%2520Little%253A%2520Alexithymia%2520Moderates%2520How%2520Self-Reported%2520Physiological%2520Hyperarousal%2520Shapes%2520Risky%2520Decisions "Share on Facebook") [![LinkedIn logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/linkedin-32px.png)](https://www.medrxiv.org/highwire_log/share/linkedin?link=http%3A%2F%2Fwww.linkedin.com%2FshareArticle%3Fmini%3Dtrue%26url%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.02.26367105v1%26title%3DFeeling%2520Too%2520Much%2520or%2520Too%2520Little%253A%2520Alexithymia%2520Moderates%2520How%2520Self-Reported%2520Physiological%2520Hyperarousal%2520Shapes%2520Risky%2520Decisions%26summary%3D%26source%3DmedRxiv "Publish this post to LinkedIn") [![Mendeley logo](https://www.medrxiv.org/sites/all/modules/highwire/highwire/images/mendeley.png)](https://www.medrxiv.org/highwire_log/share/mendeley?link=http%3A%2F%2Fwww.mendeley.com%2Fimport%2F%3Furl%3Dhttps%253A%2F%2Fwww.medrxiv.org%2Fcontent%2F10.64898%2F2026.11.02.26367105v1%26title%3DFeeling%2520Too%2520Much%2520or%2520Too%2520Little%253A%2520Alexithymia%2520Moderates%2520How%2520Self-Reported%2520Physiological%2520Hyperarousal%2520Shapes%2520Risky%2520Decisions "Share on Mendeley") [ Citation Tools](https://www.medrxiv.org/ "Citation Tools") [ Get QR code](https://connect.medrxiv.org/qr/2026.11.02.26367105) * [Tweet Widget](http://twitter.com/share?url=https%3A//www.medrxiv.org/content/10.64898/2026.11.02.26367105v1&count=horizontal&via=&text=Feeling%20Too%20Much%20or%20Too%20Little%3A%20Alexithymia%20Moderates%20How%20Self-Reported%20Physiological%20Hyperarousal%20Shapes%20Risky%20Decisions&counturl=www.medrxiv.org/content/10.64898/2026.11.02.26367105v1 "Tweet This") Reviews and Context 0 Comment 0 TRIP Peer Reviews 0 Community Reviews 0 Automated Services 0 Blogs/Media 0 Author Videos **Subject Areas** [**All Articles**](https://www.medrxiv.org/content/early/recent) * [Addiction Medicine](https://www.medrxiv.org/collection/addiction-medicine) (638) * [Allergy and Immunology](https://www.medrxiv.org/collection/allergy-and-immunology) (917) * [Anesthesia](https://www.medrxiv.org/collection/anesthesia) (350) * [Cardiovascular Medicine](https://www.medrxiv.org/collection/cardiovascular-medicine) (4989) * [Dentistry and Oral Medicine](https://www.medrxiv.org/collection/dentistry-and-oral-medicine) (494) * [Dermatology](https://www.medrxiv.org/collection/dermatology) (427) * [Emergency Medicine](https://www.medrxiv.org/collection/emergency-medicine) (675) * [Endocrinology (including Diabetes Mellitus and Metabolic Disease)](https://www.medrxiv.org/collection/endocrinology-including-diabetes-mellitus-and-metabolic-disease) (1689) * [Epidemiology](https://www.medrxiv.org/collection/epidemiology) (16248) * [Forensic Medicine](https://www.medrxiv.org/collection/forensic-medicine) (36) * [Gastroenterology](https://www.medrxiv.org/collection/gastroenterology) (1241) * [Genetic and Genomic Medicine](https://www.medrxiv.org/collection/genetic-and-genomic-medicine) (7270) * [Geriatric Medicine](https://www.medrxiv.org/collection/geriatric-medicine) (751) * [Health Economics](https://www.medrxiv.org/collection/health-economics) (1093) * [Health Informatics](https://www.medrxiv.org/collection/health-informatics) (5279) * [Health Policy](https://www.medrxiv.org/collection/health-policy) (1465) * [Health Systems and Quality Improvement](https://www.medrxiv.org/collection/health-systems-and-quality-improvement) (1830) * [Hematology](https://www.medrxiv.org/collection/hematology) (599) * [HIV/AIDS](https://www.medrxiv.org/collection/hiv-aids) (1379) * [Infectious Diseases (except HIV/AIDS)](https://www.medrxiv.org/collection/infectious_diseases) (16480) * [Intensive Care and Critical Care Medicine](https://www.medrxiv.org/collection/intensive-care-and-critical-care-medicine) (1201) * [Medical Education](https://www.medrxiv.org/collection/medical-education) (699) * [Medical Ethics](https://www.medrxiv.org/collection/medical-ethics) (156) * [Nephrology](https://www.medrxiv.org/collection/nephrology) (751) * [Neurology](https://www.medrxiv.org/collection/neurology) (7581) * [Nursing](https://www.medrxiv.org/collection/nursing) (377) * [Nutrition](https://www.medrxiv.org/collection/nutrition) (1127) * [Obstetrics and Gynecology](https://www.medrxiv.org/collection/obstetrics-and-gynecology) (1295) * [Occupational and Environmental Health](https://www.medrxiv.org/collection/occupational-and-environmental-health) (1039) * [Oncology](https://www.medrxiv.org/collection/oncology) (3740) * [Ophthalmology](https://www.medrxiv.org/collection/ophthalmology) (1091) * [Orthopedics](https://www.medrxiv.org/collection/orthopedics) (407) * [Otolaryngology](https://www.medrxiv.org/collection/otolaryngology) (465) * [Pain Medicine](https://www.medrxiv.org/collection/pain-medicine) (500) * [Palliative Medicine](https://www.medrxiv.org/collection/palliative-medicine) (143) * [Pathology](https://www.medrxiv.org/collection/pathology) (721) * [Pediatrics](https://www.medrxiv.org/collection/pediatrics) (1856) * [Pharmacology and Therapeutics](https://www.medrxiv.org/collection/pharmacology-and-therapeutics) (755) * [Primary Care Research](https://www.medrxiv.org/collection/primary-care-research) (785) * [Psychiatry and Clinical Psychology](https://www.medrxiv.org/collection/psychiatry-and-clinical-psychology) (6119) * [Public and Global Health](https://www.medrxiv.org/collection/public-and-global-health) (9976) * [Radiology and Imaging](https://www.medrxiv.org/collection/radiology-and-imaging) (2526) * [Rehabilitation Medicine and Physical Therapy](https://www.medrxiv.org/collection/rehabilitation-medicine-and-physical-therapy) (1513) * [Respiratory Medicine](https://www.medrxiv.org/collection/respiratory-medicine) (1268) * [Rheumatology](https://www.medrxiv.org/collection/rheumatology) (658) * [Sexual and Reproductive Health](https://www.medrxiv.org/collection/sexual-and-reproductive-health) (803) * [Sports Medicine](https://www.medrxiv.org/collection/sports-medicine) (595) * [Surgery](https://www.medrxiv.org/collection/surgery) (801) * [Toxicology](https://www.medrxiv.org/collection/toxicology) (109) * [Transplantation](https://www.medrxiv.org/collection/transplantation) (318) * [Urology](https://www.medrxiv.org/collection/urology) (307) Evaluation/discussion of this paper x Comments 0TRiP 0Community 0Automated 0Blogs/Media 0Video 0 Comments medRxiv aims to provide a venue for anyone to comment on a medRxiv preprint. Comments are moderated for offensive or irrelevant content (this can take ~24 h). Please avoid duplicate submissions. The content of a comment is not endorsed by medRxiv. medRxiv is now using a new commenting interface powered by Hypothes.is. All comments previously submitted via the legacy platform (Disqus) have been transferred to the new platform using the medRxiv_admin account. Please read our [commenting guide](https://connect.biorxiv.org/news/2022/03/21/commenting_on_preprints) for more information. Share this comments tab (click to copy link)Copied! TRiP medRxiv partners with journals and review services to enable posting of peer reviews and editorial decisions related to preprints they are evaluating. Reviews are posted with the consent of the authors. TRiP reviews are part of a peer review pilot project in which participating organizations post peer reviews of manuscripts they are evaluating _There is no TRiP material for this paper._ Community Reviews medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Community reviews for this article: _There are no community reviews for this paper._ Automated Evaluations Certain services provide automated analysis of preprints. Analyses invited by the authors are displayed at the top of this tab. Those done independently of authors are shown underneath . None of these analyses is endorsed by medRxiv. Automated Evaluations: _There are no automated evaluations for this paper._ Blog/Media Links medRxiv aims to inform readers about online discussion of this preprint occurring elsewhere. The content at the links below is not endorsed by either medRxiv or the preprint's authors. Video medRxiv partners with conferences and institutions to display recordings of talks and seminars related to preprints. These are posted with the consent of
## Related Clinical Research

- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)
- [fMRI-based ARC tool differentiates SuperAgers from Alzheimer’s with strong AUC](https://medichelpline.com/clinical-feed/medical-news-today-2-new-brain-imaging-tool-distinguishes-between-alzheimer-s-disease-and-superagers.md)
- [Bilateral Carotid Artery Stenosis Linked to Slightly Higher Restless Legs Syndrome Risk](https://medichelpline.com/clinical-feed/medrxiv-23-carotid-artery-stenosis-is-associated-with-restless-legs-syndrome-in-the.md)
- [Tongue–Jaw Timing Differences in ALS Versus Other Dysarthrias During [kai]](https://medichelpline.com/clinical-feed/medrxiv-2-inter-articulatory-timing-of-vocalic-tongue-body-and-jaw-movements-across.md)
- [High-resolution map of the basal ganglia reveals cell types tied to Parkinson’s and schizophrenia](https://medichelpline.com/clinical-feed/stat-news-1-stat-scientists-debut-map-of-basal-ganglia-a-key-brain-region-involved-in-an.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.